AGENUS INC (AGEN) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $30.07M; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $30.07M; Long-term Debt and Lease Obligation, Including Current MaturitiesUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $30.19M; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $30.19M; Long-term Debt and Lease Obligation, Including Current MaturitiesUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $44.66M; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $44.66M; Long-term Debt and Lease Obligation, Including Current MaturitiesUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term DebtUSD (m); Long-term Debt and Lease Obligation, Including Current MaturitiesUSD (m).
AGENUS INC Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-term Debt and Lease Obligation, Including Current Maturities USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount USD | Long-term Debt and Lease Obligation, Current USD | Long-term Debt and Lease Obligation USD | Convertible Notes Payable USD | Debt Instrument, Convertible, Beneficial Conversion Feature USD | Debt Instrument, Unamortized Discount, Noncurrent USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $30.07M | (m) | $30.07M | (m) | $30.35M | $284.00K | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $30.19M | (m) | $30.19M | (m) | $30.53M | $338.00K | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $44.66M | (m) | $44.66M | (m) | $45.50M | $845.00K | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $10.61M | $23.60M | $34.21M | (m) | $35.58M | $1.38M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $10.72M | $23.15M | $33.87M | (m) | $35.77M | $1.90M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $731.00K | $32.85M | $33.58M | (m) | $35.98M | $2.40M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $2.70M | $30.47M | $33.17M | (m) | $35.20M | $2.03M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $13.40M | $0.00 | (m) | $13.40M | $13.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $13.43M | $0.00 | (m) | $13.43M | $13.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $13.57M | $0.00 | (m) | $13.57M | $13.80M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $146.00K | $12.77M | (m) | $12.91M | $13.10M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $387.00K | $12.72M | (m) | $13.11M | $13.40M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $622.00K | $12.67M | (m) | $13.29M | $13.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $1.02M | $12.63M | (m) | $13.65M | $14.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $575.00K | $12.58M | (m) | $13.16M | $13.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $13.46M | (m) | (m) | $13.46M | $13.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $13.70M | (m) | (m) | $13.70M | $13.80M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $14.18M | (m) | (m) | $14.18M | $14.30M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $728.00K | $12.82M | (m) | $13.55M | $13.80M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $542.00K | $12.79M | (m) | $13.33M | $13.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $838.00K | $18.95M | (m) | $19.79M | $20.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $1.46M | $18.91M | (m) | $20.38M | $20.70M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $833.00K | $18.88M | (m) | $19.71M | $20.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $1.18M | $18.84M | (m) | $20.03M | $20.40M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $1.53M | $18.81M | (m) | $20.34M | $20.70M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $646.00K | $12.58M | (m) | $13.23M | $13.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $646.00K | $13.38M | (m) | $14.03M | $14.15M | $120.00K | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $13.85M | (m) | (m) | $13.85M | $14.15M | $299.00K | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $13.68M | (m) | (m) | $13.68M | $14.15M | $467.00K | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $13.52M | (m) | (m) | $13.52M | $14.15M | $629.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $146.00K | $13.21M | (m) | $13.36M | $14.15M | $788.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $146.06K | $13.05M | (m) | $13.20M | $14.15M | $946.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $146.06K | $12.91M | (m) | $13.05M | $14.15M | $1.09M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $146.06K | $12.77M | (m) | $12.91M | $14.15M | $1.23M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $20.64M | $142.39M | (m) | $163.03M | $129.15M | $1.58M | $20.64M | $142.38M | (m) | (m) | $1.58M |
| 2017-09-30 | $19.96M | $123.29M | (m) | $143.25M | $114.15M | $1.72M | $19.96M | $123.29M | (m) | (m) | $1.72M |
| 2017-06-30 | $146.06K | $138.53M | (m) | $138.68M | $114.15M | $1.85M | (m) | $138.53M | (m) | (m) | $1.85M |
| 2017-03-31 | $146.06K | $134.16M | (m) | $134.30M | $114.15M | $1.98M | (m) | $134.16M | (m) | (m) | $1.98M |
| 2016-12-31 | $146.06K | $130.54M | (m) | $130.69M | $114.15M | $1.53M | (m) | $130.54M | (m) | (m) | $1.53M |
| 2016-09-30 | $146.06K | $126.26M | (m) | $126.41M | $114.15M | $1.80M | (m) | $126.26M | (m) | (m) | $1.80M |
| 2016-06-30 | $146.06K | $122.13M | (m) | $122.27M | $114.15M | $2.05M | (m) | $122.12M | (m) | (m) | $2.05M |
| 2016-03-31 | $146.06K | $118.16M | $118.31M | (m) | $114.15M | $2.30M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $146.06K | $114.33M | (m) | $114.47M | $114.15M | $2.54M | (m) | $114.33M | (m) | (m) | $2.54M |
| 2015-12-31 | (m) | (m) | $114.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $146.06K | $110.55M | $110.70M | (m) | $114.15M | $2.76M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $146.06K | (m) | (m) | (m) | $14.10M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $423.84K | (m) | (m) | (m) | $14.40M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-02-20 | (m) | (m) | (m) | (m) | (m) | $3.00M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $1.26M | $4.77M | $6.03M | (m) | $6.26M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $6.72M | (m) | $7.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $7.43M | (m) | $7.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $2.87M | (m) | $8.80M | (m) | (m) | (m) | (m) | (m) | $1.21M | (m) | (m) |
| 2013-12-31 | $3.52M | (m) | (m) | (m) | $9.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $9.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) |
| 2013-09-30 | $3.26M | (m) | (m) | (m) | $10.20M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $2.43M | (m) | (m) | (m) | $10.20M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $201.48K | (m) | (m) | (m) | $39.20M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $204.09K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | $39.20M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $2.00M | (m) |
| 2012-09-30 | $210.47K | (m) | (m) | (m) | $39.30M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $2.40M | (m) |
| 2012-06-30 | $212.47K | (m) | (m) | (m) | $39.40M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $203.03K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $197.68K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $988.00K | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | $37.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $196.20K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $146.06K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $146.06K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |